SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending following its Q4 delivery report, which indicated vehicle delivery figures below market expectations. While some investors see the miss as already priced in and highlight record energy storage deployments, the community remains divided. The ongoing debate centers on the company's core automotive business grappling with declining sales in key European markets versus its long-term potential in AI, robotics, and new ventures, alongside discussions of a potential SpaceX IPO.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

Nio is trending as record December and Q4 delivery numbers, alongside approaching one million cumulative vehicle deliveries, are sparking renewed optimism among investors. While many anticipate potential Q4 profitability and a market re-evaluation given the strong performance and growing battery swap network, a significant portion of the community expresses frustration over persistent stock manipulation preventing sustained price appreciation.

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Ironwood Pharmaceuticals is seeing significant interest after providing exceptionally strong 2026 financial guidance, far exceeding market expectations for both revenue and EBITDA, driven by robust LINZESS sales projections. The community is actively discussing the company's clear undervaluation and high institutional ownership, fueling anticipation for a potential acquisition amidst the current surge in biotech M&A activity.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is currently trending as its AI chip unit, Kunlunxin, filed for a Hong Kong IPO, drawing significant investor enthusiasm for China's domestic AI technology. The community is buzzing over the potential for Baidu's AI capabilities, with discussions highlighting claims that Kunlunxin chips are being adopted by prominent AI models. This development reinforces Baidu's strategic positioning to capitalize on the country's push for semiconductor independence and its broader expansion in the AI sector.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals (AUPH) is currently trending due to intense speculation surrounding an imminent buyout, fueled by reported institutional accumulation and strong underlying fundamentals. The community is actively discussing anticipated updates on the AUR200 pipeline's Phase 2 indications, which many believe will unlock significant value. Despite positive momentum, a vocal segment of shareholders expresses frustration with current management's communication and eagerly awaits clarity on the company's strategic future.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is actively trending as the community discusses its recently finalized acquisition of Ask Sage, a strategic move bolstering its secure generative AI capabilities for defense and regulated sectors. Investors are closely watching for contract announcements and debating the significance of a pending share authorization vote, with many drawing parallels to the growth trajectory of Palantir in the government AI space.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is a major talking point as the community keenly observes its attempts to break through significant resistance, fueling a strong debate between bulls anticipating a robust rally and bears predicting continued dips and market manipulation. Discussions also center on the potential impact of upcoming legislative developments, which could further shape its trajectory in the broader market.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies (BMNR) is trending amidst intense debate surrounding an upcoming shareholder vote on a significant increase in authorized shares, at a time when its stock is perceived to be decoupling from Ethereum's price movements. The community is vocal with criticism, largely accusing management of continuous shareholder dilution that erodes value and questioning the credibility of its leadership, while a smaller contingent anticipates a potential rebound after recent selling pressure.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending due to significant community concerns surrounding its ongoing share dilution and the impending MSCI reclassification decision. Many investors are expressing frustration over the stock's underperformance relative to Bitcoin and are keenly discussing the potential for substantial selling pressure if it's removed from key indexes, scrutinizing the efficacy of its Bitcoin acquisition strategy.

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Sensei Biotherapeutics Inc

Sensei Biotherapeutics (SNSE) is trending as the community debates the implications of its ongoing strategic review, which includes exploring a potential sale or merger, coupled with a notable cash position and an exceptionally low public float. Many anticipate a significant short squeeze and parabolic upside, drawing comparisons to other volatile low-float stocks, though others caution about the risks of a pump-and-dump given the company's operational shifts.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
